← Leaderboards
Richard Herbert Aster
Bloodcenter Of Wisconsin, Inc.
$12,040,804
Attributed
$12,040,804
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $903.4K · FY2005–19$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$12,040,804 · 6
By mechanism
R01$8,749,347 · 1
T32$1,256,810 · 1
P01$1,136,772 · 2
R21$457,875 · 1
R56$440,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Bloodcenter Of Wisconsin, Inc.
Same institution · by research overlap
- Peter J Newman$21,473,700
- Janice G Mc Farland$2,072,071
- Julie A Peterson$367,057
Others in their field
Top investigators on “Thrombocytopenia”
- Thomas L Ortel · Duke University$23,613,789
- Mortimer Poncz · University Of Pennsylvania$19,917,641
- Joseph E Italiano · Brigham And Women'S Hospital$12,297,098
- Douglas Brock Cines · Duke University$11,304,101
- Gregory William Henkel · Arisan Therapeutics, Inc.$10,706,799
- Karin Maria Hoffmeister · Versiti Blood Health, Inc.$10,379,020
Research focus
ThrombocytopeniaHeparinThrombosisGrantAntibodiesTransfusionPlatelet Factor 4MolecularClinical ResearchImmunePathogenesisDiagnosisPharmaceutical PreparationsBlood CellsBlood PlateletsLaboratoriesMedicineMorbidity - Disease RateReactionMediatingHuman SubjectAnticoagulantsCytopeniaDrug Sensitivity
Grant awards (34)
Hemorrhagic Diseases$531,710
R01 · FY2019 · HL · contact PI
Hemorrhagic Diseases$531,710
R01 · FY2018 · HL · contact PI
Hemorrhagic Diseases$531,710
R01 · FY2017 · HL · contact PI
Hemorrhagic Diseases$516,224
R01 · FY2016 · HL · contact PI
Hemorrhagic Diseases$508,480
R01 · FY2015 · HL · contact PI
Hemorrhagic Diseases$505,900
R01 · FY2014 · HL · contact PI
Hemorrhagic Diseases$491,446
R01 · FY2013 · HL · contact PI
Prevalence and immunogenicity of HNA-3a and -3b antibodies and antigens$208,125
R21 · FY2012 · HL · contact PI
Hemorrhagic Diseases$528,826
R01 · FY2011 · HL · contact PI
Prevalence and immunogenicity of HNA-3a and -3b antibodies and antigens$249,750
R21 · FY2011 · HL · contact PI
Hemorrhagic Diseases$528,774
R01 · FY2010 · HL · contact PI
Hemorrhagic Diseases$514,210
R01 · FY2009 · HL · contact PI
Research Training In Transfusion Medicine$170,558
T32 · FY2009 · HL · contact PI
Hemorrhagic Diseases$440,000
R56 · FY2008 · HL · contact PI
Research Training In Transfusion Medicine$169,184
T32 · FY2008 · HL · contact PI
Hemorrhagic Diseases$476,994
R01 · FY2007 · HL · contact PI
Hemorrhagic Diseases$476,932
R01 · FY2006 · HL · contact PI
Pathogenesis of Thrombocytopenia Induced by GPIIb/IIIa Inhibitors$317,091
P01 · FY2006 · HL · contact PI
RESEARCH TRAINING IN TRANSFUSION SCIENCE$109,395
T32 · FY2006 · HL · contact PI
Hemorrhagic Diseases$474,182
R01 · FY2005 · HL
RESEARCH TRAINING IN TRANSFUSION SCIENCE$43,895
T32 · FY2005 · HL
Hemorrhagic Diseases$460,371
R01 · FY2004 · HL
Research Training in Transfusion Science$187,635
T32 · FY2004 · HL
Hemorrhagic Diseases$446,964
R01 · FY2003 · HL
RESEARCH TRAINING IN TRANSFUSION SCIENCE$181,000
T32 · FY2003 · HL
HEMORRHAGIC DISEASES$420,430
R01 · FY2002 · HL
Immunobiology of GPIIb/IIIa$273,227
P01 · FY2002 · HL
RESEARCH TRAINING IN TRANSFUSION SCIENCE$171,617
T32 · FY2002 · HL
HEMORRHAGIC DISEASES$408,185
R01 · FY2001 · HL
Immunobiology of GPIIb/IIIa$273,227
P01 · FY2001 · HL
RESEARCH TRAINING IN TRANSFUSION SCIENCE$80,631
T32 · FY2001 · HL
HEMORRHAGIC DISEASES$396,299
R01 · FY2000 · HL
Immunobiology of GPIIb/IIIa$273,227
P01 · FY2000 · HL
RESEARCH TRAINING IN TRANSFUSION SCIENCE$142,895
T32 · FY2000 · HL